According to the National Institute on Alcohol Abuse and Alcoholism, based on 2024 national survey data, 7.5% of US adults with past year alcohol use disorder received any treatment at all. Only 2.4% received medication for it. That is roughly one person in forty.
Medications for alcohol cravings have existed for decades. They are not experimental, they are not a substitute for everything else, and they are not addictive. They are simply not on most people's mental list of what treatment looks like, and frequently not on their doctor's either.
Looking for treatment options for Alcohol Use Disorder?
Browse open clinical trials near you! We'll handle the follow-up.
What is actually approved
- Naltrexone. Blocks the opioid receptors involved in alcohol's rewarding effect. Drinking becomes less satisfying, which tends to reduce how much people drink rather than forcing abstinence. Available as a daily tablet or a monthly injection.
- Acamprosate. Acts on the glutamate system, which stays unsettled for months after heavy drinking stops. Used to help people who have already stopped stay stopped.
- Disulfiram. The oldest of the three. Causes an unpleasant physical reaction if you drink. Works through deterrence rather than craving, so it depends heavily on wanting that arrangement.
Two more are used off label with real evidence behind them: topiramate, and gabapentin, which is often used during the withdrawal period. Both are prescribing decisions for a clinician, not something to arrange yourself.
The Sinclair Method
You may run into this name. It is an approach built around naltrexone in which the tablet is taken before drinking rather than every day, with the aim of gradually weakening the learned link between alcohol and reward. It has a devoted following and a smaller evidence base than daily naltrexone. If it interests you, it is a conversation to have with a prescriber rather than a protocol to run alone.
You do not have to be sober first
This is the misconception that keeps the most people out. Naltrexone in particular is often started while someone is still drinking, because reducing drinking is a legitimate goal in itself. Plenty of alcohol research works the same way: many studies enrol people who are currently drinking and measure whether the treatment reduces heavy drinking days, not only whether it produces total abstinence.
If you have been waiting until you have got it under control before asking for help, that is backwards, and the research design agrees with you.
Alcohol withdrawal medication is a different job
It is worth separating two things that often get mixed up. Reducing cravings and getting through withdrawal are different problems, and they use different medicines.
The three approved medications above are for the long game. Alcohol withdrawal medication is for the first few days after heavy drinking stops, and it usually means benzodiazepines, given on a tapering schedule under medical supervision. Gabapentin for alcohol withdrawal is also widely used, and it is one of the few options that carries over into the weeks afterwards, since it can help with the sleep problems and anxiety that linger once the acute phase is over.
There is one fact here that most people have backwards. Of all the substances people withdraw from, alcohol is the one that can actually kill you. Opioid withdrawal is deeply unpleasant and rarely directly fatal. Severe alcohol withdrawal can produce seizures and delirium tremens, and without treatment it carries a real mortality risk. Anyone who drinks heavily every day should not stop abruptly on their own without talking to a clinician first.
This is also why alcohol studies are structured the way they are. Research in this area includes medical monitoring by design, which for some participants is the first proper medical oversight of their drinking they have ever had.
What research is testing now
As of September 2026 there are 234 studies recruiting in alcohol use disorder in the US, including 33 involving naltrexone and 14 involving topiramate. The active questions are:
Better matching. Naltrexone works very well for some people and barely at all for others. Studies are testing whether genetics or drinking pattern can predict who responds.
New mechanisms. Compounds acting on pathways beyond the three approved drugs, including medicines developed for other conditions.
Reduction rather than abstinence. Trials measuring fewer heavy drinking days as a real outcome, which reflects what most people actually want.
Delivery. Getting medication to people through primary care, telehealth and pharmacies instead of specialist clinics, since access is clearly the bottleneck.
In a study, the medication and the medical monitoring are provided as part of the research at no cost to participants. For people who have looked at the price of a monthly injection without insurance, that is not a small detail.
Our overview of alcohol use disorder treatment options covers the wider picture. Learn more about current research!
Common questions
What is the most effective medication for alcohol cravings? Naltrexone has the strongest evidence for reducing heavy drinking, and acamprosate has the better record for helping people who have already stopped stay stopped. Which suits you depends on your goal and your medical history.
Do I have to stop drinking before starting medication? Not for naltrexone, which is often started while someone is still drinking. Acamprosate is designed for after you have stopped. Disulfiram requires abstinence by definition.
Is naltrexone addictive? No. It is an opioid antagonist, meaning it blocks these receptors rather than activating them. It cannot produce a high and does not cause dependence.
Why do so few people get these medications? Mostly awareness. Alcohol treatment is still culturally associated with meetings and residential programmes, many primary care clinicians rarely prescribe for it, and most people never learn that a prescription is an option.
How long does alcohol stays in your system? Alcohol leaves your blood at a fixed rate of about one standard drink per hour, so most people clear it within a few hours. However, urine tests for the metabolite EtG can detect drinking for 24 to 72 hours, and up to about 120 hours after heavy drinking. Blood PEth testing can detect it for weeks.
See Alcohol Use Disorder clinical trials recruiting now
Browse open studies, filter by location, and apply in about 5 minutes: Alcohol Use Disorder Clinical Trials